Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.37 |
| ▸ | CCR6 | P51684 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 2/20 | 0.30 |
| ▸ | CNR2 | P34972 | 2/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.30 |
| ▸ | RELA | Q04206 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6327308 | 1.00 | TYR (0.37) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6325471 | 0.96 | TYR (0.35) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6331669 | 0.96 | TYR (0.41) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6331667 | 0.96 | TYR (0.41) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6325468 | 0.96 | TYR (0.35) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6332136 | 0.94 | TYR (0.44) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6332133 | 0.94 | TYR (0.44) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6327705 | 0.94 | TYR (0.42) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6327710 | 0.94 | TYR (0.42) | TYRCCR6PPARGTSHRALDH1A1 | |
| SCHEMBL6331186 | 0.90 | TYR (0.41) | TYRCCR6PPARGTSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | ZEON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1420005-A1 | CYCLOPENTANONE DERIVATIVE | Zeon Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | PTGIS, CYP51A1, TRPA1 | TYR 1890/4885CCR6 777/4885PPARG 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.